Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan
· Delayed Price · Currency is TWD 30.75
+0.15 (0.49%)
Mar 10, 2026, 10:22 AM CST
Sinphar Pharmaceutical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,820 | 5,652 | 5,694 | 5,560 | 4,847 | 5,191 | Upgrade
|
| Market Cap Growth | 1.68% | -0.75% | 2.41% | 14.71% | -6.62% | 59.54% | Upgrade
|
| Enterprise Value | 6,755 | 6,596 | 6,880 | 6,634 | 6,118 | 6,688 | Upgrade
|
| Last Close Price | 30.60 | 28.80 | 28.24 | 26.76 | 23.16 | 24.67 | Upgrade
|
| PE Ratio | 16.91 | 18.55 | 15.18 | 24.75 | - | - | Upgrade
|
| Forward PE | - | 21.48 | 21.48 | 21.48 | 21.48 | 21.48 | Upgrade
|
| PS Ratio | 1.74 | 1.79 | 1.92 | 1.95 | 1.99 | 2.17 | Upgrade
|
| PB Ratio | 1.63 | 1.59 | 1.68 | 1.73 | 1.58 | 1.65 | Upgrade
|
| P/TBV Ratio | 1.79 | 1.77 | 1.88 | 1.96 | 1.86 | 2.01 | Upgrade
|
| P/FCF Ratio | 14.56 | 16.01 | 6621.12 | 19.59 | - | 2179.26 | Upgrade
|
| P/OCF Ratio | 10.17 | 9.52 | 19.21 | 13.07 | 35.76 | 35.46 | Upgrade
|
| EV/Sales Ratio | 2.02 | 2.09 | 2.32 | 2.32 | 2.51 | 2.80 | Upgrade
|
| EV/EBITDA Ratio | 10.33 | 12.22 | 13.28 | 14.85 | 95.71 | 59.36 | Upgrade
|
| EV/EBIT Ratio | 16.44 | 22.20 | 23.83 | 33.40 | - | - | Upgrade
|
| EV/FCF Ratio | 16.89 | 18.68 | 7999.47 | 23.38 | - | 2807.81 | Upgrade
|
| Debt / Equity Ratio | 0.47 | 0.54 | 0.57 | 0.60 | 0.69 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 2.56 | 3.52 | 3.75 | 4.28 | 33.06 | 19.04 | Upgrade
|
| Debt / FCF Ratio | 4.18 | 5.39 | 2261.46 | 6.74 | - | 905.50 | Upgrade
|
| Net Debt / Equity Ratio | 0.19 | 0.20 | 0.25 | 0.21 | 0.29 | 0.31 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.03 | 1.34 | 1.67 | 1.50 | 13.91 | 8.54 | Upgrade
|
| Net Debt / FCF Ratio | 1.68 | 2.05 | 1004.31 | 2.36 | -83.59 | 404.16 | Upgrade
|
| Asset Turnover | 0.54 | 0.50 | 0.48 | 0.46 | 0.39 | 0.40 | Upgrade
|
| Inventory Turnover | 2.40 | 2.35 | 2.22 | 2.17 | 1.86 | 1.96 | Upgrade
|
| Quick Ratio | 1.51 | 1.30 | 1.46 | 1.36 | 1.22 | 1.24 | Upgrade
|
| Current Ratio | 2.21 | 1.84 | 2.20 | 1.92 | 1.76 | 1.91 | Upgrade
|
| Return on Equity (ROE) | 9.50% | 8.21% | 10.79% | 5.22% | -6.59% | -5.44% | Upgrade
|
| Return on Assets (ROA) | 4.15% | 2.96% | 2.90% | 2.00% | -1.85% | -1.27% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.25% | 6.47% | 7.09% | 3.39% | -4.53% | -2.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.20% | 6.10% | 5.70% | 4.20% | -3.90% | -2.50% | Upgrade
|
| Earnings Yield | 5.94% | 5.39% | 6.59% | 4.04% | -0.79% | -0.55% | Upgrade
|
| FCF Yield | 6.87% | 6.25% | 0.01% | 5.10% | -0.22% | 0.05% | Upgrade
|
| Dividend Yield | 3.09% | 3.31% | 3.12% | 3.30% | 0.76% | 0.71% | Upgrade
|
| Payout Ratio | 100.95% | 55.04% | 44.71% | 14.93% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.07% | -0.02% | 0.00% | -0.17% | - | 0.07% | Upgrade
|
| Total Shareholder Return | 3.02% | 3.28% | 3.13% | 3.12% | 0.76% | 0.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.